Evaluating the RESET care program: Advancing towards scalable and effective healthcare solutions for metabolic dysfunction-associated liver disease

Figure 1 Clinical benefits of digital therapeutics in metabolic dysfunction-associated liver disease. The clinical advantages of digital therapeutics in the management of metabolic dysfunction-associated liver disease are substantial. Essential components encompass personalized interventions aimed at weight reduction and the enhancement of liver health, alongside behavioral and psychological support. Additionally, cognitive behavioral therapy, exercise interventions, and dietary modifications are crucial aspects of this approach. These elements are seamlessly integrated through digital platforms, thus providing continuous and tailored support to foster patient engagement and improve health outcomes. MASLD: Metabolic dysfunction-associated liver disease.